Pfizer-BioNTech COVID-19 vaccine, aprub na sa Canada

ni Ronalyn Seminiano Reonico | December 10, 2020

Inaprubahan na ng Canada ang paggamit ng Pfizer-BioNTech COVID-19 vaccine noong Miyerkules. Saad ng Health Canada, "The data provided supports favourably the efficacy of Pfizer-BioNTech COVID-19 vaccine as well as its safety.

"The efficacy of the vaccine was established to be approximately 95 percent. The vaccine was well tolerated by participants and has no important safety concerns. The benefit-to-risk assessment for Pfizer-BioNTech COVID-19 vaccine is considered favourable."

Pahayag ni Canadian Deputy Chief Public Health Officer Howard Njoo, “At last we have a reason to feel optimistic and excited about returning to the lives we led pre-COVID.”

Paalala naman ni Prime Minister Justin Trudeau, “It doesn’t mean we can let our guards down.”

Samantala, naaprubahan man, hindi pa rin sigurado kung gaano katagal ang efficacy ng Pfizer vaccine kaya magsasagawa pa rin umano ng "risk management plan" ang Health Canada upang ma-monitor ang tagal ng bisa nito at makakalap ng iba pang data para rito.

COVID-19 vaccine, 90% effective na

ni Thea Janica Teh | November 10, 2020

Isang COVID-19 vaccine na gawa ng Pfizer at BioNTech sa Paris, France ang napag-alamang epektibo na ng 90% sa pagpapatuloy nito sa Phase 3 trial.

Matapos mabigyan ng dalawang dose na may pagitan ng 28 araw, naprotektahan ng vaccine ang mga pasyente laban sa COVID-19. Ayon kay Pfizer Chairman at CEO Alberto Bourla, "The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine's ability to prevent COVID-19."

Ito umano ay isa nang malaking pag-asa na malapit nang magawa ang COVID-19 vaccine na makakapuksa sa krisis pangkalusugan ng buong mundo.

"We are reaching this critical milestone in our vaccine development program at a time when the world needs it most," dagdag ni Bourla.

Inaasahan na gagawa ang kumpanya ng halos 50 milyong vaccine doses para sa buong mundo ngayong 2020 at 1.3 bilyon sa darating na 2021.